Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $236K invested in Kazia Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
13% more funds holding
Funds holding: 8 → 9 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
28% less capital invested
Capital invested by funds: $328K → $236K (-$91.7K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$11.4K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$5.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$48.3K |
| 2 |
Morgan Stanley
New York
|
-$14.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $189K | -$14.3K | -292 | -7% |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| $18K | -$48.3K | -990 | -73% |
|
|
VF
3
Virtu Financial
New York
| $12K | +$11.4K | +233 | New |
|
|
4
BNP Paribas Financial Markets
Paris,
France
| $8.46K | +$5.08K | +104 | +158% |
|
5
RhumbLine Advisers
Boston,
Massachusetts
| $7.55K | – | – | – |
|
|
NA
6
NewEdge Advisors
New Orleans,
Louisiana
| $498 | – | – | – |
|
7
Bank of America
Charlotte,
North Carolina
| $199 | – | – | – |
|
|
AF
8
Allworth Financial
Folsom,
California
| $87 | – | – | – |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $25 | – | – | – |
|
|
AF
10
Advisornet Financial
Minnetonka,
Minnesota
| $5 | – | – | – |
|
KZIA Hedge Fund Activity: Q3 2023 in Review
9 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2023, worth a combined $236K — down 28% from $328K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new KZIA positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $11.4K. The largest seller was Acadian Asset Management, cutting an estimated $48.3K.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2023, up from 8 in Q2 2023.
- Funds reported $236K of Kazia Therapeutics stock for Q3 2023, down 28% quarter-over-quarter.
- 1 fund opened new Kazia Therapeutics positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Kazia Therapeutics buyer in Q3 2023 was Virtu Financial, an estimated $11.4K added.
- The largest Kazia Therapeutics seller in Q3 2023 was Acadian Asset Management, an estimated $48.3K sold.
Based on aggregated 13F filings for Q3 2023.